INTRODUCTION
Neutrophils play an essential role in the body's defence against pathogens [1] . On exposure to pathogenic stimuli, neutrophils respond by generating toxic oxygen species such as superoxide anion (O # − )) and other potent microbiocidal agents [1] . The generation of these oxidants by neutrophils occurs through the activation of a membrane-associated complex known as the NADPH oxidase. In resting cells, the components of the NADPH oxidase are segregated into cytosolic and membrane compartments ; however, the cytosolic components are translocated to the plasma membrane during activation and assemble with membrane-bound components, resulting in the active O # − )-generating system (reviewed in [2, 3] ).
The key membrane-associated component of the NADPH oxidase is a heterodimeric flavocytochrome b, which is composed of a 91 kDa glycoprotein (gp91 phox ) and a 22 kDa protein (p22 phox ) (reviewed in [4, 5] ). Flavocytochrome b has been reported to contain all of the redox components of the NADPH oxidase [6] [7] [8] and is responsible for the direct transfer of electrons from NADPH to O # . During activation of the neutrophil NADPH oxidase, p47 phox binds directly to flavocytochrome b [9] [10] [11] , and at least six regions of flavocytochrome b have been identified as binding sites for p47 phox [9, [12] [13] [14] [15] [16] [17] . The first of these binding sites reported was identified by Kleinberg et al. [9, 11] , who found that synthetic peptides mimicking the C-terminus of gp91 phox inhibited O # − ) generation in a cell-free NADPH oxidase assay system and in permeabilized cells. Furthermore the active gp91 phox peptides disrupted assembly of the NADPH oxidase complex by blocking the interaction between flavocytochrome b and p47 phox . Nakanishi et al. [12] subsequently confirmed these studies, and our recent Abbreviations used : Tr-NOESY, transferred-nuclear Overhauser effect spectroscopy. ¶ To whom correspondence should be addressed.
suggesting they were more flexible. Therefore further refinement was performed on the Ser&-Phe"% region of the peptide after omitting the ends of the peptide from consideration. In this case, two similar structures were obtained. Both structures again exhibited extended open-bend conformations. In addition, the amino acid side chains that showed evidence of immobilization on binding to p47 phox correlated directly with those that were found previously to be essential for biological activity. Thus during NADPH oxidase assembly, the C-terminus of gp91 phox binds to 47 phox in an extended conformation between gp91 phox residues 555 and 564, with immobilization of all of the amino acid side chains in the &&)RGVHFIF&'% region except for His&'". analysis of p47 phox using random-sequence peptide phage-display mapping was consistent with the presence of a p47 phox -binding site on the C-terminus of gp91 phox [17] . Thus p47 phox binds to flavocytochrome b at multiple peptide domains on both subunits, including two or more sites on the C-terminus of gp91 phox , and synthetic peptides representing these domains on gp91 phox can compete with gp91 phox for binding to p47 phox .
Transferred nuclear Overhauser spectroscopy (Tr-NOESY) NMR has been used to study the structure of protein-protein contact interfaces by providing information on the bound structures of peptide sequences that block the interactions of interest [18] [19] [20] . In the present report, Tr-NOESY NMR techniques were used to study the conformation of a synthetic gp91 phox C-terminal mimetic peptide, &&"SNSESGPRGVHFIFNKEN&'), when it was bound to recombinant p47 phox . Our results show that this gp91 phox peptide binds to p47 phox in an extended open-bend conformation between Ser&&& and Phe&'%. These experiments also provide direct evidence supporting the immobilization of certain key amino acid side chains of the gp91 phox C-terminus during its interaction with p47 phox .
MATERIALS AND METHODS

Preparation and fractionation of neutrophils
Human neutrophils were isolated as described previously using dextran sedimentation followed by Histopaque density-gradient separation [21] . Membrane and cytosolic fractions were prepared by sequential centrifugation of cavitated neutrophils as described previously [17] and stored at k70 mC.
Synthetic peptide
The gp91 phox peptide, &&"SNSESGPRGVHFIFNKEN&'), was synthesized on a Milligen 9050 peptide synthesizer and purified by preparative HPLC. Peptide preparations were found to have a mass of 2019 by electrospray MS, equal to the theoretical mass, and less than 2 % contamination by species of other molecular masses was detected.
The synthetic gp91 phox C-terminal peptide was evaluated in a cell-free NADPH oxidase assay and in an electropermeabilized neutrophil system to confirm its biological activity. In the cellfree oxidase assay system [17] , the peptide fully inhibited NADPH oxidase activity with an IC &! of approx. 50 µM (data not shown). This peptide also inhibited NADPH oxidase activity in electropermeabilized neutrophils at less than 100 µM [22] , confirming the cell-free assay results. These results are consistent with those of Kleinberg et al. [9, 11] using similar peptides.
Production and purification of recombinant p47
phox Recombinant p47 phox was produced in recombinant baculovirusinfected Sf9 cells and purified to homogeneity by the methods of Leto et al. [23] . The purity ( 99 %) and identity of the recombinant p47 phox were confirmed by SDS\PAGE and Western blotting with anti-p47 phox antibodies [24] . In addition, the recombinant p47 phox was found to be active in reconstituting NADPH oxidase activity in a recombinant cell-free reconstitution system using neutrophil plasma membranes and recombinant cytosolic proteins [25] , confirming that the recombinant p47 phox preparations were biologically active.
Preparation of NMR samples
Samples of gp91 phox C-terminal peptide were dissolved at 2n5 mM in 500 µl of 50 mM sodium phosphate, pH 6n5, containing 10 % #H # O and 0n75 % 3-(trimethylsilyl)-[2,2,3,3-#H]propionic acid (sodium salt) (TSP), and the pH was readjusted to 6n5. For NMR analysis of the bound peptide, 250 µl of 4n0 mM gp91 phox peptide (prepared in 50 mM sodium phosphate, pH 6n5, plus 0n75 % TSP) was added dropwise to 200 µl of recombinant p47 phox (25 mg\ml in 50 mM sodium phosphate buffer, pH 6n5) with frequent adjustment of the pH to 6n5. #H # O was added to bring the total volume to 500 µl, and final concentrations of peptide and p47 phox were 2n0 mM and 200 µM respectively. We noticed that some preparations of the peptide\protein mixture were initially fully soluble but tended to precipitate over time. Thus care was taken to ensure that samples used for NMR measurements had little or no precipitated material.
NMR spectroscopy
NMR spectra were measured on a Bruker AM 500 spectrometer using a proton-selective probe. TOCSY spectra [26] were collected at 1 mC with a MLEV-17 spin lock time of 100 ms. NOESY spectra [27] were collected at several temperatures, including 1 mC with mixing times of 75, 100, 125, 150, 200 and 300 ms. Mixing times were randomly varied over a range of p10 % in order to reduce effects of zero-quantum coherence transfer [28] . All spectra were acquired with the RF carrier on the water resonance which was suppressed with coherent decoupler irradiation in the case of TOCSY or with jump and return read pulses in NOESY [29, 30] . Residual water was further suppressed by a convolution function [31] . The transmitter phase and preacquisition delay were adjusted for NOESY spectra to eliminate the requirement for phase adjustment of the spectra during processing, which greatly improved baseline flatness [32] . For NOESY, the initial D0 delay in t " was adjusted to be equal to IN\2 l 47n5 µs minus an allowance of 4τ\π for the finite lengths (τ) of the jump and return read pulses [33] , and the phase in t " was set to PH0 l 45 and PH1 lk90, which resulted in greatly improved baseline flatness. NMR data were processed on Silicon Graphics workstations using FELIX (Hare Research Inc.) macros written at Montana State University by Christophe Lambert. Typically, 60m-shifted sine bell apodization functions were applied in t # and t " with zero filling to 2048 complex points. A 1\sin (∆ω D2) correction was applied to the NOESY intensity in F # to compensate for the non-uniform jump and return excitation, where ∆ω is the offset from the water resonance and D2 is the delay between the jump and return pulses. This correction retrieved intensity losses due to jump and return detection, which are particularly important in the α proton region close to water (C. Lambert and E. A. Dratz, unpublished work).
Proton T " ρ relaxation experiments were carried out with the RF carrier set on the resonance of interest during spin lock and acquisition and then moved to the H # O resonance during the relaxation delay where weak phase-coherent irradiation was used to suppress the solvent H # O. Spin lock times were varied from 1 to 300 ms, and peak amplitudes were measured using a cubic spline-corrected baseline. T " ρ values were measured as a function of spin lock power from 200 to 21 000 Hz. Spin lock powers were directly calibrated by 180m pulse length measurements between 21 000 and 2400 Hz and calculated from the attenuator settings at lower powers. T " and T # relaxation experiments were carried out with inversion recovery and Carr-Purcell-Meiboom-Gill spin echo sequences, respectively with coherent presaturation for solvent suppression.
NOESY peak volumes were obtained using FELIX.
T " values were found to be rather constant along the peptide spectrum in the presence of p47 phox . NOESY cross-peak intensities were divided by the volume of a resolved diagonal peak to correct for cross-peak intensity loss due to T " relaxation and to provide fractional NOESY intensities. The fractional NOESY intensities of the free peptide were subtracted from the observed fractional Tr-NOESY intensities in the presence of p47 phox to obtain the bound fractional NOESY intensities [see eqn. (1)]. This procedure assumes that the peptides are in fast exchange with their proteinbinding sites on the cross-relaxation time scale, an assumption that was supported by the T " ρ measurements, as explained in the results. The bound fractional NOESY intensities at a mixing time of 200 ms were converted into approximate proton distances, using the isolated two-spin approximation and the side-chain amino protons of Asn (1n8 A H ) as a reference intensity. Other proton pairs with known separation distances and resolved resonances such as Ile γ " kγ # were not stereospecifically assigned and were treated as pseudo-atoms in the MARDIGRAS refinements.
Molecular dynamics, simulated annealing and a variety of analysis routines in the Discover v2n8, InsightII v2.2, X-PLOR v3.1 and NMRchitect v2.0 packages (Biosym) were used in the structure analysis. Pseudo-atom corrections [34] were applied to the distance constraints involving methylene and methyl groups. All NOESY distance constraints were initially applied with force constants of 100 kcal\(mol:A H #) and the force constants were manipulated in simulated annealing as described below. Chirality restraints were applied on all chiral atoms and omega angle restraints were applied with force constants of 300 kcal\(mol:rad#) to maintain peptide bonds in the trans conformation. Families of ISPA structures obtained from simulated annealing were used as starting points for a MARDIGRAS [35] full relaxation matrix analysis to obtain improved distance constraints. Programs required for conversion of Biosym file formats to MARDIGRAS formats were written by David Poole in our laboratory.
RESULTS
H NMR spectra of the free gp91
phox carboxyl-tail peptide
The "H NMR spectra of the 18-amino acid gp91 phox C-terminal peptide (&&"SNSESGPRGVHFIFNKEN&')) was assigned using a combination of two-dimensional TOCSY and NOESY NMR [36] , and Table 1 shows the resonance assignments. Sequential assignments were readily accomplished from residues 2 to 18 with the aid of the sequential NH-αH and the NH-NH connectivity using the longer mixing time NOESYs. Most of the amide to α-cross-peaks within the same residue were resolved in the TOCSY NH-αH fingerprint region except for overlapping Ser& NH-αH and Phe"% NH-αH cross-peaks. The Asn# NH-αH cross-peak was not observed in TOCSY, but was seen in NOESY.
The Ser" resonances were not identified because of the lack of an NH signal and partial overlap with Ser$ and Ser&.
NMR spectroscopy of the gp91 phox carboxyl-tail peptide bound to p47 phox
The central goal of the present experiments was to study the p47 phox -bound conformation of the gp91 phox carboxyl-tail peptide. To accomplish this goal, we performed Tr-NOESY measurements on the peptide in exchange with p47 phox , and Figure 1 shows contour plots of the fingerprint and aliphatic regions of the Tr-NOESY and free peptide NOESY spectra. These regions showed significant differences between the free-and boundpeptide spectra, while the amide region (not shown) only showed intensity differences between the two spectra. The resonance assignments of the peptide in exchange with the protein could be carried over from the free peptide since the relatively low fraction bound (" 0n1) led to relatively small chemical-shift changes in the presence of p47 phox . The Tr-NOESY cross-relaxation rate observed for protons i and s on a ligand in fast exchange with a high-molecular-mass receptor is :
where p f and p b are the mole fractions and σ f is and σ b is are the cross-relaxation rates of the free and bound ligand respectively [37] . Figure 1 , while the chemical shift and appearance of the observed peptide NMR spectra are dominated by the excess free species.
In order for the simple form of eqn (1) to be valid, the peptide off-rate (k −" ) must be considerably faster than the fastest crossrelaxation rate of the ligand in the bound state (σ b is ) [37] . Ligand off-rates were measured using T " ρ relaxation experiments as a function of the strength of the applied spin locking RF field (ω SL ) [38, 39] . Davis et al. [39] showed that the T " ρ relaxation rate of a ligand in exchange between the free and bound states (R ex " ρ ) can be described as a weighted sum of 1\T " and 1\T # in the bound and free states plus an exchange term as shown in their equation number 24. Crucial variables are ∆ω, which is the difference in chemical shift between the free and bound species ; the off-rate k ex l (p f ) −" k −" $ k −" ; and ∆ω o , the difference between the RF frequencies and the resonance frequency observed for the ligand when it is in exchange with the receptor. In the present experiments, ∆ω o l 0 since the RF carrier was set on the observed resonance peak of the ligand of interest when it was in exchange with receptor and therefore, ∆ω o l 0 and sin β l 1 in equation 24 of Davis et al. [39] .
Although most of the peptide resonances showed little chemical-shift difference due to binding to p47 phox , several resonance shifts were observed, and we investigated peaks that showed the largest shifts on binding to p47 phox for investigation by T " ρ . The larger the ∆ω, the greater the difference in precession rate of the spin of interest between the bound and free states. When the dephasing due to ∆ω approaches a rate similar to the k −" process, there is a loss of spin lock and a faster decay in the amplitude of the detected magnetization. The Gly' αH and Asn"& NH side-chain proton resonances both exhibited easily detectable changes in chemical shift between the free and bound peptide. Because of uncertainties in the exact fraction of p47 phox that was able to bind peptide during the relaxation measurements, the fraction bound (p b ) and ∆ω were varied along with k ex to obtain the best fit to the data. The position of the inflection point in the T " ρ rate as a function of ω SL is set primarily by the value of k ex and indicated that the off-rate was approx. 1000 s −" .
Mixing concentrated p47 phox with the peptide often caused precipitation of the sample at lower pH values ( 6n0), whereas higher pH values caused a loss in NH signal intensity due to proton exchange. Therefore the best compromise for maintaining NH signal intensity and solubility was found to be at pH 6n5, and, in samples where solubility was maintained, rather short Tr-NOESY spectra were run because of concerns that precipitation might occur. Therefore a relatively low number of scans and t " transients were used, and the Tr-NOESY measuring times were less than 8 h at each mixing time. These shorter measuring times, combined with the modest peptide concentration attainable, gave Tr-NOESY spectra with a modest signal-to-noise ratio. As 
Figure 1 Contour plots of the fingerprint and aliphatic regions of the Tr-NOESY and NOESY NMR spectra
-terminal peptide
The peptide backbone atoms of the two structures having the best agreement with the Tr-NOESY distance constraints after three cycles of refinement were superimposed.
shown in Figure 1 , the addition of 0n2 mM p47 phox to 2 mM gp91 phox C-terminal peptide caused a large increase in many of the NOESY cross-peaks, while some of the cross-peaks decreased in intensity. Many cross-peak intensities in the aliphatic sidechain region increased significantly in the presence of p47 phox , especially in the region of Arg) to Lys"'. A total of 126 Tr-NOESY cross-peaks was identified, which provided 98 i,i and 28
i,i-1 distance constraints. Long-range Tr-NOESY cross-peaks were not detected, suggesting that the peptide was in an extended conformation when bound to p47 phox . Initial distance constraints (derived from the isolated two-spin approximation) were taken from the bound peptide Tr-NOESY intensities that had been corrected for free peptide contributions and T " relaxation as described in the Materials and methods section. Tr-NOESY distance constraints, trans-peptide ω dihedral constraints, and chirality restraints were used in simulated annealing [40] to generate 20 trial structures. From these 20 structures, five structures were picked which had the lowest relative energies and best distance agreements. These five structures were then used as starting points for an iterative full relaxation matrix MARDIGRAS distance-refinement procedure [35] . MARDIGRAS-generated distance constraints are sensitive to the effective correlation time (τ eff c ) of the ligand. When the ligand is bound to the receptor, it is expected to have a correlation time approaching that of the receptor. Therefore τ eff c of the gp91 phox Cterminal peptide in fast exchange represents a weighted average of the bound and free correlation times. The approximate correlation time of p47 phox is 24 ns using the Stokes-Einstein equation, which assumes a compact spherical shape for the protein. At a fraction bound (p b ) of 0n1, the effective τ c of the peptide would be " 2n4 ns. If a portion of the p47 phox in the preparation was not available to bind peptide because of misfolding and\or non-specific aggregation or if the bound peptide experienced more local motion than the whole protein, τ eff c could be lower. In addition, p47 phox could also have a longer correlation time than an equivalent sphere. Therefore τ eff c values slightly above and considerably below 2n4 ns (0n6, 0n8, 1n0, 2n0 and 3n0 ns) were used in MARDIGRAS refinements for each of the trial structures. The three lowest τ eff c values (0n6, 0n8 and 1n0 ns) gave the best Q and R values, which are measures of internal agreement with the data in the MARDIGRAS distance refinements [41] . Alternatively, the effective mixing time for the bound species was taken to be p b times the experimental mixing time (e.g. 0n1i200 ms l 20 ms) [42] . In this case, the bound cross-relaxation rates are 10-fold larger (1\p b ) and a range of bound τ c values was used (10, 12, 14, 16, 18, 20, 24, 30 ns) in MARDIGRAS. The best Q and R values were found at bound τ c values of 14 and 16 ns with very similar best-fit distances.
Molecular dynamics was run using the MARDIGRAS distances from the three lowest correlation times as restraints and using the five starting structures derived from the prior round of simulated annealing as starting points, to generate 15 new sets of structures. The structures were analysed for RMS distance agreement, ω dihedral violations, and relative energy ; a best structure was selected from each set. The 15 structures were then each subjected to another round of MARDIGRAS refinement. The MARDIGRAS refinement gave the best Q and R agreement with the data at an effective τ c of 1n0 ns. The resulting 15 sets of MARDIGRAS distances were used in constrained molecular dynamics, and these runs were analysed for RMS distance agreements and relative energies. The structure refinement was iterated again with a third round of MARDIGRAS. The structures obtained with a τ c of 1n0 ns had fewer distance violations than the structures obtained with either slower or longer correlation times. The Q and R factors and the MARDIGRAS distances were very similar in the second and third rounds of refinement, and therefore it was concluded that further refinement would produce no further improvement.
Five clusters of structures of the bound gp91 phox C-terminal peptide had the best internal agreement, lowest energy and lowest restraint violations, but none of the five sets was clearly preferred by the combination of these criteria (Figure 2A) . However, all sets of structures had an extended open bend in the region of Ser& to Phe"%, while the bound structure was poorly defined outside of the Ser&-Phe"% region (Figure 2A ). Superimposition of the backbone atoms from residues Ser& to Phe"% using the lowest energy frame from each of the five structure clusters indicated that the bound structure of the peptide between Figure 4 Comparison of the observed and back-calculated cross-peak intensities for each of the refined structures shown in Figure 3 The percentage difference between the back-calculated and experimentally observed intensity was calculated for each cross-peak using the following equation : [(Back-calculated intensitykobserved intensity)/observed intensity]i100.
Table 2 Comparison of NOESY intensities between protons within amino acid side chains of the free and p47
phox -bound gp91 phox peptide Bound intensities were obtained by subtracting the free intensities from the intensities observed in the presence of p47 phox and dividing the result by the fraction bound, which was assumed to be 0n1. In the event that the fraction bound was lower, the bound NOESY intensities would be even larger. Ser& and Phe"% was indeed very similar in all of these structures ( Figure 2B ). As shown in Figure 2 , the conformation of the residues from Ser"-Ser$ and Lys"&-Asn") was poorly defined by the data. Therefore these residues were removed from structural consideration, the co-ordinates of the best structures from Ser&-Phe"% were randomized, and several rounds of simulated annealing and MARDIGRAS analysis were performed. This refinement resulted in two similar sets of structures that also exhibited extended or somewhat open-bend conformations (Figure 3 ). To confirm that these structures accurately represented our experimental data, we back-calculated the spectrum for each refined structure and found that the majority of back-calculated cross-peak intensities were very similar to the experimental cross-peak intensities ( Figure 4 ). Larger deviations (" 20 % difference) occurred only for those cross-peaks that had unresolved proton peaks. Both sets of refined structures also had very low NOE violations ; only four cross-peaks had NOE violations 0n5 A H , and the maximum distance violation for any one cross-peak did not exceed 0n7 A H . These results indicate a good agreement between the calculated and experimentally observed data. The small NOE violations observed probably resulted from uncertainties in the NOE intensity measurements and\or the presence of local motion.
Certain amino acid side chains showed large increases in Tr-NOESY intensities in the presence of p47 phox relative to the free peptide NOESYs (Figure 1 and Table 2 ), indicating that these particular side chains are significantly immobilized when the peptide binds to p47 phox . As summarized in Table 2 , our data show that the amino acid side chains between residues 8 and 16 of the peptide, except for His"", appear to interact strongly with p47 phox . The Gly* protons did not show detectable splitting, and therefore a Tr-NOESY cross-peak could not be observed between them.
DISCUSSION
Previous studies have demonstrated that gp91 phox C-terminal peptides can block assembly of the neutrophil NADPH oxidase by disrupting the interaction between flavocytochrome b and the p47 phox protein [9, 11, 12] . In the present studies, we extend these observations to : (1) provide direct evidence supporting this binding interaction, (2) define the regions of intimate contact between the gp91 phox C-terminal peptide and p47 phox , and (3) obtain information on the three-dimensional conformation of the peptide when it is bound to p47 phox .
In the presence of p47 phox , many Tr-NOESY cross-peaks of the gp91 phox C-terminal peptide showed significant increases in intensity compared with those observed for the free peptide (see Figure 1 and Table 2 ). The increases in cross-peak intensities indicate substantial immobilization of many of the amino acid side chains in the peptide via interaction with p47 phox . The Tr-NOESY cross-peaks of the bound gp91 phox C-terminal peptide did not show long-range intramolecular interactions, suggesting an extended conformation of this peptide when bound to p47 phox , and the peptide backbone structures shown in Figures 2 and 3 are consistent with this conclusion. The gp91 phox C-terminal peptide bound to p47 phox contains an extended open bend between Ser& and Phe"% with close association of most of the amino acid side chains with p47 phox (except His"") and a poorly defined structure outside of this central region. This type of extended conformation is not inconsistent with the biochemical function of this binding site which contributes to a high-affinity multisite binding interaction that occurs between p47 phox and gp91 phox [9, [12] [13] [14] [15] [16] [17] .
Peptide ligands have been shown to bind to target proteins in extended or open conformations in a number of systems studied with Tr-NOESY or X-ray diffraction, including a hexapeptide substrate bound to porcine pancreatic elastase [43] , a dodecapeptide of the nicotinic acetylcholine receptor bound to α-bungarotoxin [44] , a platelet receptor peptide bound to bovine α-thrombin [45] and endogenous peptides bound to the MHC I [46] and MHC II proteins [47] . In addition, other types of structure have been found for peptide ligands when bound to target proteins, including α-helices [19] and more complex shapes [20] .
Using alanine substitution on similar peptides to the peptide studied here, Kleinberg et al. [11] reported that the residues corresponding to Arg), Val"!, Phe"#, Ile"$ and Phe"% of the peptide we studied were all essential for inhibitory activity in NADPH oxidase assays. Substitution of alanine for Gly* or His"" had little effect on the inhibitory activity of these peptides. In addition, extensions of the peptide on either end of this Arg)-Phe"% region did not increase activity. Our results are consistent with these previous biochemical data and now show directly that the biologically active residues are those residues that also experience the strongest immobilization when interacting with p47 phox (Table 2) . Since some neighbouring residues outside of the minimal region conferring activity (Arg)-Phe"%) also showed significant chemical shifts when bound to p47 phox , our data suggest that these peptide regions may contribute in some way to binding of the peptide to p47 phox , although they do not seem to confer further inhibitory activity on the peptide. In any case, the direct correlation between the changes in Tr-NOESY cross-peak intensities determined here and the peptide amino acid sequence requirements for biological activity determined previously by Kleinberg et al. [11] are consistent with each other.
A number of potential problems can arise in interpreting Tr-NOESY data, including viscosity artifacts and influences of spin diffusion between the ligand and its protein-binding site. In these experiments, we did not observe significant broadening of ligand signals in the presence of p47 phox , indicating that viscosity did not significantly contribute to the changes we observed in Tr-NOESY cross-peak intensities [48] . As described above in the Materials and Methods and Results sections, the exchange rate of the gp91 phox C-terminal peptide appears to be sufficiently fast, relative to the cross-relaxation between protons on the bound peptide, to be interpreted in the fast-exchange limit for Tr-NOESY. In the fast-exchange region, the effective mixing time in Tr-NOESY is equivalent to the experimental mixing time (up to 300 ms in our experiments) multiplied by the fraction of ligand bound ( 0n1 in the present experiments) [42, 49] . Thus the spin diffusion to the protein would be effective for 30 ms or less in our experiments, assuming all of the protein bound peptide and for approx. 15 ms if only half of the p47 phox was folded correctly or accessible to bind ligand (lower limit). Such short effective mixing times tend to reduce the influence of spin diffusion while the peptide is bound. In addition, intramolecular spin diffusion can be largely accounted for by complete relaxation matrix analysis, as was done here using MARDIGRAS [50] .
Tr-NOESY NMR analysis of peptide ligands bound to protein receptors appears to be a useful approach to obtain structural information on regions of protein-protein interactions. The phagocyte NADPH oxidase is a multicomponent enzyme complex, the assembly of which involves the interaction of at least six different protein components and therefore many sites of protein-protein contact. The present studies provide a starting point to define the structural nature of this assembly and provide a basis for the further understanding of how the activation of the oxidase is regulated at the molecular level. In addition, this type of structural information might eventually be used to guide the synthesis of non-peptide mimetic compounds with higher affinity that would have potential therapeutic usefulness in treating inflammatory diseases.
